Enzymatic Release
Enzymatic Release - Related Videos
06:01
A Dye Release Assay to Quantify Enzymatic Activity of Antimicrobial Proteins
0 Views •
2025
This video demonstrates the dye release assay for quantifying the enzymatic activity of antimicrobial proteins. The antimicrobial protein degrades the bacteria's dye-labeled cell wall and releases the dye molecules turning the solution blue. The absorbance of the solution correlates with the enzymatic activity of the antimicrobial protein.
11:31
High-throughput Screening of Recalcitrance Variations in Lignocellulosic Biomass: Total Lignin, Lignin Monomers, and Enzymatic Sugar Release
0 Views •
Cited by 19 •
2015
Plant cell wall structure and chemistry traits are evaluated to identify ideal feedstocks for biofuels and bio-materials. Standard methods have limitations when applied to large data sets. These high-throughput pretreatment, enzyme saccharification, and pyrolysis-molecular beam mass spectrometry methods compare large numbers of biomass samples with decreased experimental time and cost.
09:58
Light-driven Enzymatic Decarboxylation
0 Views •
Cited by 6 •
2016
We describe a protocol for the light-catalyzed generation of hydrogen peroxide — a cofactor for oxidative transformations.
10:00
Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
0 Views •
Cited by 12 •
2015
Enzymatic microelectrode biosensors enable real-time measurements of extracellular cell signaling in biologically-relevant concentrations. The following protocols extend the applications of biosensors to the ex vivo and in vivo detection of ATP and H2O2 in the kidney.
13:00
Hot Biological Catalysis: Isothermal Titration Calorimetry to Characterize Enzymatic Reactions
0 Views •
Cited by 16 •
2014
Isothermal titration calorimetry measures heat flow released or absorbed in chemical reactions. This method can be used to quantify enzyme-catalysis. In this paper, the protocol for instrumental setup, experiment running, and data analysis is generally described, and applied to the characterization of enzymatic urea hydrolysis by jack bean urease.
FAQs
Selectivity comes from the enzyme recognizing a particular substrate or linker associated with the payload. Cleavage therefore depends on the molecular compatibility between the enzyme and the bond that connects or retains the cargo. In bioengineering designs, this recognition can help distinguish the intended release site from other components, supporting controlled availability of drugs, proteins, nucleic acids, or other bioactive molecules.
The enzyme must encounter suitable environmental conditions for catalytic activity, and the relevant substrate or linker must be present in the carrier, matrix, or conjugate. Adjusting these conditions can influence when and where bond cleavage occurs. This responsiveness allows researchers to connect payload liberation with a biological environment or engineered setting rather than relying only on unrestricted release.
Carrier and linker choices determine how the payload is associated with the system and which bond the enzyme can cleave. A design may retain a molecule within a matrix, attach it through a molecular conjugate, or keep it in an encapsulated form. Matching that structure with an appropriate enzyme creates a route for converting enzyme activity into payload availability.
A typical design begins by selecting the payload and its carrier, matrix, or conjugate arrangement. Researchers then incorporate a substrate or linker that the chosen enzyme can recognize and establish conditions that support cleavage. The resulting system is evaluated by whether enzyme activity liberates the intended molecule, allowing the design to be refined for timing or location of release.
This approach is useful when researchers need release to respond to enzyme activity rather than occur without a biological or environmental trigger. Applications described for bioengineering include therapeutic delivery, biosensing, tissue engineering, and biomolecule processing. The same principle can support different payload classes, including drugs, proteins, nucleic acids, and other bioactive compounds.
By linking bond cleavage to enzyme activity, these systems can make a payload available at a selected time or location. That capability may help researchers tune delivery behavior, improve biomaterial performance, and create condition-responsive designs. In therapeutic delivery, the released molecule can be a drug or other bioactive compound; in biomaterials, release behavior can be integrated into engineered system function.